1. Home
  2. NTIP vs ACXP Comparison

NTIP vs ACXP Comparison

Compare NTIP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTIP
  • ACXP
  • Stock Information
  • Founded
  • NTIP 1990
  • ACXP 2017
  • Country
  • NTIP United States
  • ACXP United States
  • Employees
  • NTIP N/A
  • ACXP N/A
  • Industry
  • NTIP Multi-Sector Companies
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTIP Miscellaneous
  • ACXP Health Care
  • Exchange
  • NTIP Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • NTIP 37.5M
  • ACXP 33.9M
  • IPO Year
  • NTIP 1998
  • ACXP 2021
  • Fundamental
  • Price
  • NTIP $1.62
  • ACXP $2.43
  • Analyst Decision
  • NTIP
  • ACXP Strong Buy
  • Analyst Count
  • NTIP 0
  • ACXP 1
  • Target Price
  • NTIP N/A
  • ACXP $12.00
  • AVG Volume (30 Days)
  • NTIP 22.2K
  • ACXP 76.9K
  • Earning Date
  • NTIP 08-08-2024
  • ACXP 08-12-2024
  • Dividend Yield
  • NTIP 6.21%
  • ACXP N/A
  • EPS Growth
  • NTIP N/A
  • ACXP N/A
  • EPS
  • NTIP N/A
  • ACXP N/A
  • Revenue
  • NTIP $2,064,000.00
  • ACXP N/A
  • Revenue This Year
  • NTIP N/A
  • ACXP N/A
  • Revenue Next Year
  • NTIP N/A
  • ACXP N/A
  • P/E Ratio
  • NTIP N/A
  • ACXP N/A
  • Revenue Growth
  • NTIP 284.36
  • ACXP N/A
  • 52 Week Low
  • NTIP $1.52
  • ACXP $1.17
  • 52 Week High
  • NTIP $2.60
  • ACXP $8.82
  • Technical
  • Relative Strength Index (RSI)
  • NTIP 48.73
  • ACXP 55.14
  • Support Level
  • NTIP $1.56
  • ACXP $1.99
  • Resistance Level
  • NTIP $1.62
  • ACXP $3.33
  • Average True Range (ATR)
  • NTIP 0.07
  • ACXP 0.22
  • MACD
  • NTIP 0.01
  • ACXP 0.04
  • Stochastic Oscillator
  • NTIP 43.48
  • ACXP 32.96

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Share on Social Networks: